COVID-19: use of ACE inhibitors and angiotensin-receptor blockers
Posted 25 Mar 2020
David Millar-Jones examines recent newspaper stories on the use of ACE inhibitors and angiotensin-receptor blockers in people with COVID-19, and their implications for primary care
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.